Colinz Laboratories Ltd
BSE:531210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Risen Energy Co Ltd
SZSE:300118
|
CN |
Colinz Laboratories Ltd
Total Current Liabilities
Colinz Laboratories Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Colinz Laboratories Ltd
BSE:531210
|
Total Current Liabilities
₹20.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Current Liabilities
₹151B
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Current Liabilities
₹63B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Current Liabilities
₹234.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Current Liabilities
₹108.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Current Liabilities
₹44.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Colinz Laboratories Ltd
Glance View
Colinz Laboratories Ltd. engages in the manufacture of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectable, ointments, and creams. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2004-01-13. The firm operates and supplies medicines in the domestic market. The Company’s products include oncology, ayurvedic and nutraceuticals. Its oncology products include imatinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, doxorubicin, filgrastim and pegylated liposome doxorubicin. Its ayurvedic products include anti-diarrheas, anti-pyrectics, anti-inflammatories, anti-spasmodic, cough syrups, appetite stimulating agents, memory boosters, anti-piles, antacids, liver tonic, ulcer healing agents, digestive agents, drugs to treat oligospermia and erectile dysfunction, ear drops, uterine tonic, anti-diabetics, and general tonics.
See Also
What is Colinz Laboratories Ltd's Total Current Liabilities?
Total Current Liabilities
20.5m
INR
Based on the financial report for Dec 31, 2025, Colinz Laboratories Ltd's Total Current Liabilities amounts to 20.5m INR.
What is Colinz Laboratories Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
2%
Over the last year, the Total Current Liabilities growth was -26%. The average annual Total Current Liabilities growth rates for Colinz Laboratories Ltd have been -6% over the past three years , -1% over the past five years , and 2% over the past ten years .
